Notice of Results & Presentations
Diaceutics PLC will announce its unaudited half-year results for the period ended 30 June 2026 on Tuesday, 22 September 2026. An analyst and investor webinar presentation will be held on the same day at 1400 BST. The company, which works with 21 of the top 30 pharmaceutical companies, aims to redefine commercialization for diagnostic-driven therapies.
Select text to share a quote on X · sign in to keep highlights & notes in your DXRX notes
New York, Belfast and London, 8 September 2026 - Diaceutics PLC (AIM: DXRX), the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies, will announce its unaudited results for the half year ended 30 June 2026 on Tuesday, 22 September 2026.
Analyst Presentation:
A webinar presentation for analysts and investors will be held at 1400 BST (0900 EDT) on Tuesday, 22 September 2026. Those wishing to attend can register their interest using the following link:
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.